Table 2 Associated Co-morbidities of Patients with and without Severe Vision Impairment/Blindness (SVI/B)
From: Severe vision impairment and blindness in hospitalized patients: a retrospective nationwide study
Co-morbidities | Patients without SVI/B N (%) | Patients with SVI/B N (%) | p-value |
|---|---|---|---|
Total | 30,363,917 (99.8) | 37,200 (0.2) | |
Charlson comorbidity score | < 0.01 | ||
0 | 11,902,655 (39.2) | 5,691 (15.3) | |
1 | 5,860,235 (19.3) | 5,914 (15.9) | |
2 | 4,099,128 (13.5) | 5,580 (15.0) | |
3 or more | 8,441,168 (27.8) | 19,790 (53.2) | |
Opioid use | 637,642 (2.1) | 446 (1.2) | < 0.01 |
Tobacco use | 5,222,593 (17.2) | 3,720 (10.2) | < 0.01 |
Alcohol use | 1,366,376 (4.5) | 706 (1.9) | < 0.01 |
Depression | 242,911 (0.8) | 334 (0.9) | 0.68 |
Chronic lung disease | 4,736,771 (15.6) | 5,914 (15.9) | < 0.01 |
Hypertension | 15,880,328 (52.3) | 26,226 (70.5) | < 0.01 |
Diabetes with complications* | 4,433,131 (14.6) | 14,619 (39.3) | < 0.01 |
Peripheral vascular disease | 1,457,468 (4.8) | 3,980 (10.7) | < 0.01 |